About Loyal Health
Loyal Health provides a digital healthcare platform that improves the healthcare experience for patients and providers by offering tools like automated appointment reminders and health risk assessments. The platform helps health systems, such as hospitals and clinics, enhance patient engagement and operational efficiency while gathering valuable consumer insights. Unlike its competitors, Loyal Health operates on a subscription-based model, ensuring continuous access to its features and ongoing innovation. The company's goal is to transform healthcare operations through technology, creating a more connected and seamless care journey.
Atlanta, GeorgiaHeadquarters
2015Year Founded
$44.7MTotal Funding
SERIES_BCompany Stage
Enterprise Software, HealthcareIndustries
51-200Employees
Benefits
Flexible paid time off, sick and personal days
At least one holiday per month (sometimes, more!)
Full health, dental, and vision insurance - Loyal pays the premium for all employees!
One Time Home Office Setup Stipend For Remote & Hybrid Roles
Monthly Internet Stipend for Remote & Hybrid Roles
Long term & short term disability
401[k] plan
16 Weeks Paid Parental Leave
2 Volunteer days per year
Matching Gift Program
Participation Grant Program
Risks
Emerging digital health startups may dilute Loyal Health's market share.
Rapid technological advancements may strain Loyal Health's resources.
Economic downturns could impact Loyal Health's subscription-based revenue model.
Differentiation
Loyal Health integrates machine learning to streamline patient-provider interactions.
The platform offers a comprehensive suite of tools for healthcare accessibility and efficiency.
Loyal Health's CRM system manages automated campaigns to boost patient engagement.
Upsides
Loyal Health raised $33.5M in Series B funding to expand its offerings.
Partnership with PeaceHealth enhances provider data management and search services.
SOC 2 Type II certification ensures strong data privacy and security controls.
Funding
Total raised$44.75 M
Latest valuation$167.50 M
StageSERIES_B
SERIES B
6/30/2024$34
$167.50 MSERIES A
9/30/2020$12
$62.50 M